The MHC class II molecule I-A(g7) exists in alternate conformations that are peptide dependent

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 2059-2067

  Arneson, L S ^a   Peterson, M ^a   Sant, A J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL SURFACE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION;

EID: 0034663880     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.2059     Document Type: Article

References (62)

1. Type-I diabetes: A chronic autoimmune disease of human, mouse and rat
2. Genetic control of autoimmunity in type I diabetes
3. The role of MHC class II molecules in susceptibility and resistance to autoimmunity
4. The role of CD4 and CD8 T cells in type I diabetes in the NOD mouse
5. Molecular basis for HLA-DQ associations with IDDM
6. HLA-DQβ gene contributes to susceptibility and resistance to insulin- dependent diabetes mellitus
7. Distribution of HLA-DQA1 and -DQB1 alleles and DQA2-DQB1 genotypes among Senegalese patients with insulin-dependent diabetes mellitus
8. Population analysis of protection by HLA-DR and DQ genes from insulin- dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls
9. Polymorphic structural features of modeled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM
10. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM: Members of the Swedish Childhood Diabetes Study
11. The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex
12. Aspartate at position 57 of nonobese diabetic I-A(g7) β-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus
13. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice
14. Prevention of insulin-dependent diabetes mice by transgenes encoding modified I-A β chain or normal I-E α chain
15. The first external domain of the nonobese diabetic mouse class II I-A β chain is unique
16. Crystal structures of two I-A(d)-peptide complexes reveal that high affinity can be achieved without large anchor residues
17. Crystal structure of I-A(k) in complex with a dominant epitope of lysozyme
18. A structural framework for deciphering the link between I-A(g7) and autoimmune diabetes
19. The class II MHC I-A(g7) molecules from non-obese diabetic mice are poor peptide binders
20. Molecular characterization of the diabetes-associated mouse MHC class II protein, I-A(g7)
21. Selection of the T cell repertoire
22. T-cell development: A role for self-peptides in positive selection
23. Using thymus anatomy to dissect T cell repertoire selection
24. The role of MHC class II molecules in susceptibility to type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire
25. Invariant chain structure and MHC class II function
26. The function of invariant chain in class II-restricted antigen presentation
27. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading
28. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules
29. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM
30. Properties of monoclonal antibodies to mouse Ig allotypes, H-2 and Ia antigens
31. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens
32. Clonal analysis of B- and T-cell responses to Ia antigens
33. Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody
34. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules
35. b haplotype reveal genetic control of isotype expression
36. An altered invariant chain protein with an antigenic peptide in place of CLIP forms SDS-stable complexes with class II αβ dimers and facilitates highly efficient peptide loading
37. Invariant chain can bind MHC class II at a site other than the peptide binding groove
38. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules
39. Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes
40. Self peptides isolated from MHC glycoproteins of nonobese diabetic mice
41. Cell surface expression of hybrid murine/human MHC class II βα dimers: Key influences of residues in the amino-terminal portion of the β1 domain
42. The structure-function relationship of I-A molecules: Correlation of serologic and functional phenotypes of four I-A(k) mutant cell lines
43. Peptide-induced conformational changes in class I molecules: Direct detection by flow cytometry
44. Recognition of a single amino acid change on the surface of a major transplantation antigen is in the context of self peptide
45. Subtle conformational changes in major histocompatibility complex class II molecules by binding peptides
46. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3
47. X-ray crystal structure of HLA-DR4 (DRA(*)0[01, DRB1(*)0401) complexed with a peptide from human collagen II
48. Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides
49. Major histocompatibility complex conformational epitopes are peptide specific
50. Abundant empty class II MHC molecules on the surface of immature dendritic cells
51. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice
52. pH-dependent peptide binding properties of the type I diabetes- associated I-A(g7) molecule: Rapid release of CLIP at an endosomal pH
53. An ion pair in class II major histocompatibility complex heterodimers critical for surface expression and peptide presentation
54. Two human T cell receptors bind in a similar diagonal mode to the HLA- A2/Tax peptide complex using different TCR amino acids
55. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2
56. The crystal structure of a T cell receptor in complex with peptide and MHC class II
57. Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation
58. MHC class II interactions with CD4 mediated by a region analogous to the MHC class I binding site for CD8
59. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules
60. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response
61. Breaking self-tolerance in nonobese diabetic mice
62. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities